Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Exelixis and Ipsen start COSMIC-312 trial for advanced HCC

Hepatocellular carcinoma is the most common form of liver cancer. Credit: Ed Uthman.



  • Exelixis

Go Top